Aloe vera gel for radiation dermatitis

Evidence label: Mixed / uncertain · Clinical goal: prevent or lessen acute skin reactions during radiotherapy

Evidence at a glance

Population: adults and children receiving breast, head-and-neck or other radiotherapy.
Intervention: topical aloe vera gels or aloe-based creams; formulations varied substantially.
Result: a 100-person breast trial was negative, a head-and-neck placebo-controlled trial reported a late-treatment erythema signal, and a pediatric phase III comparator favored the non-aloe cream.

What was studied

A randomized study of 100 people receiving adjuvant breast radiotherapy compared aloe gel with no aloe and found no reduction in prevalence or severity of dermatitis.

A multicenter double-blind head-and-neck trial reported moderate-to-severe erythema at weeks 5 and 6 in 13.6% and 24.1% with aloe versus 27.8% and 42.6% with placebo (P=.05 and .038). In pediatric radiotherapy, an anionic phospholipid cream performed better than aloe gel.

What the evidence shows

Results conflict by formulation, comparator and radiation site. Aloe cannot be treated as one standardized intervention, and the positive head-and-neck percentages do not erase the negative breast and pediatric findings.

This is skin-support evidence only. Topical aloe has no role in controlling the cancer or improving radiotherapy efficacy.

Limits and uncertainty

Some studies compared aloe with no treatment, others with placebo or an active cream. Skin grading, timing, adherence and commercial preparations varied.

The detailed full texts of all trials were not independently appraised; unreported formulation chemistry, funding and missing-data handling remain uncertain.

Safety and practical context

Topical aloe is generally low risk but can cause burning, itching, rash or allergy. Oral aloe latex or non-decolorized whole-leaf products are different exposures and should not be inferred safe from topical studies.

Radiation clinics often specify what may be placed on skin and when. Moist desquamation, infection, rapidly increasing pain or fever requires clinical review.

Questions for the care team

Is the exact aloe formulation supported in my radiation site and protocol?
When may it be applied relative to treatment, and what should be avoided?
What is the clinic’s standard skin-care and topical-steroid plan?

Sources

Literature searched: October 15, 2026 · Record appraised: October 15, 2026

Educational evidence summary, not personal medical advice. Research regimens describe what was studied; they are not personal prescribing instructions and should not replace cancer treatment or individualized supportive care.